PCOS as a generational disease - risks to mother and children
DOI:
https://doi.org/10.12775/JEHS.2023.42.01.007Keywords
Hyperandrogenism, insulin resistance, PCOS, pregnancy, complications of PCOSAbstract
INTRODUCTION: Polycystic ovary syndrome (PCOS) is the dominant endocrine and metabolic disorder in young women. The incidence has increased significantly over the years and now affects approximately 6-20% of women of childbearing age.
AIM: The aim of the work is to present the current state of knowledge about PCOS, to show what complications it brings and to present the disease as a multi-generational problem.
TECHNICAL CONDITION. DESCRIPTION: It is widely accepted that hyperandrogenism plays a fundamental role in the development of most of the reproductive and metabolic disorders associated with PCOS. Excess androgens have a detrimental effect on the metabolic homeostasis of women with PCOS, acting on various metabolic tissues. PCOS is associated with reduced fertility or infertility. Women should be aware of factors affecting fertility, especially the effects of obesity and age. After pregnancy, women with PCOS have a significantly increased risk of pregnancy-related complications, including gestational diabetes, high blood pressure disorders, preterm and caesarean delivery, and pre-eclampsia.The offspring of women with PCOS may have an increased risk of birth defects and hospitalization in childhood. According to the DOHaD theory, the unfavorable uterine environment caused by mothers with PCOS, consisting in changes in fetal metabolism, may increase the susceptibility of the offspring to diseases in adulthood, according to the DOHaD theory. In addition, the offspring of PCOS are prone to a range of metabolic diseases in early adulthood, which will also affect the health of their children.
CONCLUSION: The effects of endocrine disorders affect women with PCOS as well as their offspring. Diet, weight maintenance, physical activity, anti-androgenic drugs and metformin are recommended to reduce symptoms in mothers and their children. Breaking the vicious circle of intergenerational transmission remains a huge challenge.
References
Sana Siddiqui, Somaiya Mateen , Rizwan Ahmad Shagufta Moin ,,A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)” J Assist Reprod Genet; 2022 Nov;39(11):2439-2473. doi: 10.1007/s10815-022-02625-7. Epub 2022 Oct 3.
Xin Zeng, Yuan-Jie Xie , Ya-Ting Liu , Shuang-Lian Long , Zhong-Cheng Mo ,, Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity’’Clin Chim Acta; 2020 Mar;502:214-221. doi: 10.1016/j.cca.2019.11.003. Epub 2019 Nov 13.
Miguel A. Sanchez-Garrido, Manuel Tena-Sempere ,,Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies’’ Mol Metab. 2020 May; 35: 100937. Published online 2020 Feb 5 doi: 10.1016/j.molmet.2020.01.001
Daniel A Dumesic , Luis R Hoyos , Gregorio D Chazenbalk , Rajanigandha Naik , Vasantha Padmanabhan , David H Abbott; ,,Mechanisms of intergenerational transmission of polycystic ovary syndrome’’ 2020 Jan;159(1):R1-R13. doi: 10.1530/REP-19-0197.
Giselle A Abruzzese , Aimé F Silva, Mariela E Velazquez , Maria-José Ferrer , Alicia B Motta
,,Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development” WIREs Mech Dis 2022 Sep;14(5):e1558 doi: 10.1002/wsbm.1558. Epub 2022 Apr 27.
Yue Che, Jie Yu, Yu-Shan Li, Yu-Chen Zhu, and Tao Tao*,,Polycystic Ovary Syndrome: Challenges and Possible Solutions’’ J Clin Med. 2023 Feb; 12(4): 1500. Published online 2023 Feb 14. doi: 10.3390/jcm12041500
Anju E Joham, Stefano Palomba, Roger Hart ,,Polycystic Ovary Syndrome, Obesity, and Pregnancy’’ Semin Reprod Med. 2016 Mar;34(2):93-101. doi: 10.1055/s-0035-1571195. Epub 2016 Feb 8.
Carolien M Boomsma , Bart C J M Fauser, Nick S Macklon ,,Pregnancy complications in women with polycystic ovary syndrome’’ Semin Reprod Med. 2008 Jan;26(1):72-84. doi: 10.1055/s-2007-992927.
Yuehui Zhang , Wei Zhao , Hongfei Xu, Min Hu , Xiaozhu Guo , Wenyan Jia , Guoqi Liu , Juan Li , Peng Cui , Susanne Lager , Amanda Nancy Sferruzzi-Perri , Wei Li, Xiao-Ke Wu , Yanhua Han , Mats Brännström , Linus R Shao , Håkan Billig ,,Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome’’ J Physiol 2019 Aug;597(15):3927-3950. doi: 10.1113/JP277879. Epub 2019 Jul 3.
Miguel A Sanchez-Garrido , Manuel Tena-Sempere ,,Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies’’ Mol Metab 2020 May;35:100937. doi: 10.1016/j.molmet.2020.01.001. Epub 2020 Feb 5.
. Xu H., Fu Q., Zhou Y., Xue C., Olson P., Lynch E.C., Zhang K.K., Wu C., Murano P., Zhang L., et al. A long-term maternal diet intervention is necessary to avoid the obesogenic effect of maternal high-fat diet in the offspring. J. Nutr. Biochem. 2018;62:210–220. doi: 10.1016/j.jnutbio.2018.09.008.
Franks S. Assessment and management of anovulatory infertility in polycystic ovary syndrome. Endocrinology and Metabolism Clinics of North America. 2003;32(3):639–651.
Bednarska S., Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what's new? Advances in Clinical and Experimental Medicine. 2017;26(2):359–367
6. Gilbert E.W., Tay C.T., Hiam D.S., Teede H., Moran L.J. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clinical Endocrinology (Oxf) 2018
. Moran C., Arriaga M., Rodriguez G., Moran S. Obesity differentially affects phenotypes of polycystic ovary syndrome. The Internet Journal of Endocrinology. 2012:317241. 2012.
. Baillargeon J.P., Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertility and Sterility. 2007;88(4):886–893.
. Baillargeon J.P., Nestler J.E. Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? Journal of Clinical Endocrinology & Metabolism. 2006;91(1):22–24.
Cimino I., Casoni F., Liu X., Messina A., Parkash J., Jamin S.P. Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nature Communications. 2016;7:10055.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Karolina Gendek, Anna Kozłowska, Weronika Dalmata, Ilona Gąbka, Jan Dąbrowski, Anna Korzeniowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 781
Number of citations: 0